Company News
Goldman Sachs Downgrades GE HealthCare to Neutral
Goldman Sachs lowered GE HealthCare rating from Buy to Neutral, citing macro pressures despite product momentum.
12‑month price target cut to $65 from $81, reflecting lower earnings estimates and a re